Page last updated: 2024-08-24

sertraline and Anankastic Personality

sertraline has been researched along with Anankastic Personality in 172 studies

Research

Studies (172)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.58)18.7374
1990's54 (31.40)18.2507
2000's63 (36.63)29.6817
2010's41 (23.84)24.3611
2020's13 (7.56)2.80

Authors

AuthorsStudies
Betcher, H; Pease, E; Singh, B; Ziegelmann, M1
Askari, S; Mokhtari, S; Shalbafan, M; Shariat, SV; Shariati, B; Yarahmadi, M1
Deng, F; Fu, X; Huang, L; Li, H; Li, L; Tang, X; Tao, Y; Wang, X; Wang, Y; Xu, H; Yin, L; Zhang, H; Zou, S1
Antony, G; Banaschewski, T; Briegel, W; Correll, CU; Egberts, KM; Fekete, S; Fleischhaker, C; Gerlach, M; Hellenschmidt, T; Heuschmann, P; Imgart, H; Kaess, M; Karwautz, A; Kölch, M; Malzahn, U; Plener, PL; Reitzle, K; Renner, T; Reuter-Dang, SY; Rexroth, C; Rock, H; Romanos, M; Scherf-Clavel, M; Schulte-Körne, G; Smigielski, L; Taurines, R; Theisen, F; Tini, E; Unterecker, S; Walitza, S; Wewetzer, C1
Baniasadipour, H; Mowla, A1
Eftekhar Ardebili, M; Ghobadian, A; Kamalzadeh, L; Mokhtari, S; Shalbafan, M; Shariati, B; Shati, M; Yarahmadi, M1
Cui, Z; Gong, W; Li, J; Lu, Y; Zhang, F1
Calarge, CA1
Askari, S; Eissazade, N; Shalbafan, M; Shariat, SV; Shariati, B; Shokrani, M; Yarahmadi, M1
Preskorn, SH; Rode, R1
Freidl, M; Velikić, V; Wippel, A1
Imperato, JS; Jin, YO; Li, JZ; Pappadopulos, EA; Si, T; Wang, G; Yan, L; Yang, L; Yu, W; Zou, KH1
Behler, N; Hasan, A; Kirsch, B; Kumpf, U; Leitner, B; Padberg, F; Palm, U; Wulf, L1
Dastgheib, SA; Modarresi, F; Mowla, A1
Nair, A; O'Gorman, B; O'Kearney, R; Turner, C1
Ahmad, J; Gupta, B; Kar, SK; Shrivastava, A1
Barsoum, A; Benkelfat, C; Berney, A; Cottraux, J; Diksic, M; Gravel, P; Leyton, M; Lissemore, JI; Nordahl, TE; Pinard, G; Sibon, I; Sookman, D1
de Koning, PP; Denys, D; van Bennekom, MJ1
Akaho, R; Deguchi, I; Kigawa, H; Nishimura, K1
Dahl, K; Haugland, BS; Hybel, KA; Højgaard, DRMA; Ivarsson, T; Jensen, S; Melin, K; Nissen, JB; Skarphedinsson, G; Skärsäter, I; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B1
Bernstein, GA; Carstedt, PA; Conelea, CA; Cullen, KR; Harris, EC; Lee, SS; Mueller, BA; Zagoloff, AD1
Via, E1
Avci, A; Erken, E; Gul Celik, G; Ray, PC; Tas, DA; Yolga Tahiroglu, A1
Bussing, R; Geffken, GR; Mason, DM; McNamara, JP; Meyer, JM; Murphy, TK; Reid, AM; Storch, EA1
Bustillo, JR; Lemke, NT1
Andreou, C; Giegling, I; Hegerl, U; Juckel, G; Leicht, G; Mavrogiorgou, P; Mulert, C; Pogarell, O; Popescu, V; Rujescu, D; Zaudig, M1
Bussing, R; Garvan, CS; Geffken, GR; Goodman, WK; Lewin, AB; McNamara, JP; Murphy, TK; Rahman, O; Small, BJ; Storch, EA1
Brezinka, V; Grünblatt, E; Tschakarjan, S; Walitza, S1
Amerio, A; Ghaemi, SN; Marchesi, C; Odone, A1
Compton, SN; Dahl, K; Hybel, K; Ivarsson, T; Melin, KH; Nissen, JB; Skarphedinsson, G; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B; Wentzel-Larsen, T1
Aydın, K; Barburoğlu, M; Ertekin, E; Özyıldırım, SŞ; Tükel, R1
Brissos, S; Gama-Marques, J; Jesus, G1
King, AL; Nardi, AE; Santos, V1
Compton, S; Dahl, K; Hybel, K; Ivarsson, T; Melin, KH; Nissen, JB; Skarphedinsson, G; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B; Wentzel-Larsen, T1
Hoyte, CO; Srisuma, S; Wanaukul, W; Wongvisavakorn, S1
Patterson, B; Van Ameringen, M1
Ivarsson, T; Skarphedinsson, G; Weidle, B1
Matheiken, S1
Bussing, R; Geffken, GR; Goodman, WK; Guzick, AG; McNamara, JP; Murphy, TK; Reid, AM; Storch, EA1
Belhaj, A; Ben Youssef, H; Bouasker, A; Bouden, A; Ghachem, R; Halayem, S; Othman, S; Tabbane, K1
Boostani, S; Dastgheib, SA; Mowla, A1
Cavanna, AE; Robertson, MM1
Vitiello, B1
Geffken, GR; Goldstein, RB; Goodman, WK; Lehmkuhl, H; Murphy, TK; Storch, EA1
Mendhekar, DN1
Ros, LT3
Moretti, M1
Grzesiak, M; Pacan, P; Reich, A; Szepietowski, JC1
Aigner, M; Asenbaum, S; Hornik, K; Pirker, W; Ritter, K; Stompe, T; Thau, K; Zettinig, G; Zitterl, W; Zitterl-Eglseer, K1
Allgair, A; Flessner, CA; Foa, E; Franklin, ME; Freeman, J; Garcia, A; March, J; Sapyta, J1
Gilbert, AR; Maalouf, FT1
Bär, KJ; Gohle, D; Hegerl, U; Juckel, G; Mavorgiorgou, P; Mulert, C; Pogarell, O; Rujescu, D; Winter, C; Zaudig, M1
Bogetto, F; Chiadò Piat, S; Maina, G; Rigardetto, S; Rosso, G1
Malinina, EV; Zabozlaeva, IV1
Foa, EB; Franklin, ME; Freeman, JB; Garcia, AM; March, JS; Moore, PS; Sapyta, JJ1
Borges, CP; Cordioli, AV; Ferrão, YA; Meyer, E; Sousa, MB; Souza, FP1
Gentile, S1
Foa, EB; Franklin, ME; Freeman, J; Garcia, A; March, JS; Przeworski, A; Zoellner, LA1
Cavanna, AE; Rickards, H; Worrall, R1
Bussing, R; Garvan, CW; Goodman, WK; McNamara, JP; Murphy, TK; Reid, AM; Storch, EA1
Goriunov, AV; Lobacheva, MV1
Aalouane, R; Rharrabti, S1
Brüne, M; Patzold, T1
Arnold, DH1
Francobandiera, G1
Kurs, R; Poyurovsky, M; Weizman, A1
Bhattacharyya, S; Girishchandra, BG; Khanna, S1
Chung, H; Cook, EH; Messig, M; Wagner, KD1
Hegerl, U; Juckel, G; Mavrogiorgou, P; Mergl, R; Zaudig, M2
Gal, G; Goshen, E; Hendler, T; Sasson, Y; Tzila Zwas, S; Zohar, J1
Broocks, A; Hohagen, F; Kordon, A1
Göbel, C; Hegerl, U; Juckel, G; Mavrogiorgou, P; Mergl, R; Vogel, M; Zaudig, M1
Albert, U; Bogetto, F; Maina, G; Salvi, V1
Asbahr, FR; Castillo, AR; Ito, LM; Latorre, MR; Lotufo-Neto, F; Moreira, MN1
Likasitwattanakul, S1
Austin, C; Crits-Christoph, P; Davidson, JR; Kiev, A; Koran, LM; Mandel, FS; Ninan, PT; Rasmussen, SA; Robinson, DG; Zajecka, JM1
Denys, D1
Cordioli, AV; Isolan, LR; Manfro, GG; Oliveira, RR; Sousa, MB1
Bailly, D1
Antonio, C; Maurizio, B; Silvia, M1
Barbe, R; Baumann, P; Crettol, S; Eap, CB; Garran, E; Vabre-Bogdalova, A1
Foa, E; Franklin, ME; Freeman, J; Garcia, A; Leonard, H; March, JS; Moore, P1
Fernandez, HH; Nguyen, FN; Okun, MS; Pauly, RR1
Geffken, GR; Lehmkuhl, H; Murphy, TK; Storch, EA; Touchton, A1
Coffey, B; Kotcher, L; Wieland, N1
O'Kearney, R1
Bonnot, O; Cohen, D; Warot, D1
Fineberg, NA; Ipser, J; Pallanti, S; Pampaloni, I; Stein, DJ1
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A1
Ghanizadeh, A1
Podgórski, JK; Roś, LT1
Corrêa, H; Lage, NV; Rocha, FF1
Oner, O; Oner, P1
Ağargün, MY; Aşkin, R; Aydin, A; Beşiroğlu, L; Uğuz, F; Yilmaz, E1
Akman, C; Cilli, AS; Kaya, N; Sahingoz, M; Uguz, F1
Koran, LM; Thienemann, M1
Menkes, DB1
Chouinard, G; DuBoff, E; Greist, JH; Halaris, A; Jefferson, JW; Kim, SW; Kobak, KA; Koran, L; Liebowtiz, MR; Lydiard, B1
Chouinard, G; DuBoff, E; Greist, J; Halaris, A; Kim, SW; Koran, L; Liebowitz, M; Lydiard, RB; Rasmussen, S; White, K1
Bellantuono, C; Piccinelli, M; Pini, S; Wilkinson, G1
Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC1
Lydiard, RB1
Calamari, JE; Faber, SD; Hitsman, BL; Poppe, CJ1
Deltito, JA1
Allen, L; Tejera, C1
Jackson, CW; Lydiard, RB; Morton, WA1
Zinner, SH1
Bakish, D; Joffe, RT1
Hollander, E; Josephson, SC; Stein, DJ1
Lamberti, JS; Wiener, K1
Goodman, WK; McDougle, CJ; Price, LH2
Cole, JO; Kando, JC; Tohen, M; Weiss, MK; Zarate, CA1
Gilman, D; Hayden, CT; Kalivas, J; Kalivas, L1
Rush, AJ; Suppes, T1
Byerly, MJ; Christensen, R; Goodman, WK1
Koran, LM; Maloney, A; Mueller, K1
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH1
Beach, K; Nesbitt, L; Richman, H; Sallee, FR; Sethuraman, G1
Labbate, LA; Oleshansky, MA1
Olivera, AO1
Byerly, MJ; Christensen, RC; Cuadros, C; Dodt, JE1
Bouwer, C; Stein, DJ; van Heerden, B1
Dryden-Edwards, RC; Reiss, AL1
Brenner, EM; King, RA; Lynch, KA; Scahill, L; Vitulano, LA1
Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH1
Bisserbe, JC; Flament, MF1
Atala, KD; Baer, L; Beer, DA; Eisen, JL; Phillips, KA; Rasmussen, SA1
DuBoff, E; Greist, J; Hackett, E; Halaris, A; Koran, LM; Liebowitz, M; Lydiard, RB; McElroy, S; Mendels, J; O'Connor, K; Rasmussen, S1
Alderman, J; Chung, M; Johnston, HF; Wolkow, R1
Grace, JJ; Pato, MT; Priest, B; Rahman, MS1
Biederman, J; Cook, EH; Cutler, NR; Dominguez, R; Ferguson, J; March, JS; Mardekian, J; Muller, B; Riesenberg, R; Rosenthal, M; Safferman, A; Sallee, FR; Steiner, H; Wagner, KD; Wolkow, R1
Benazzi, F1
Clary, CM1
Apter, J; Asnis, G; Bystritsky, A; Curtis, G; Du Pont, IJ; Ferguson, J; Kronig, MH; Landbloom, R; Munjack, D; Phillips, K; Riesenberg, R; Robinson, D; Roy-Byrne, P1
Biederman, J; Faraone, SV; Fine, CS; Geller, D; March, JS; Millstein, RB; Spencer, TJ; Wilens, TE; Wolkow, R1
Lee, CD; Lee, DO1
Couturier, J; Steele, M1
Marazziti, D; Pallanti, S1
Black, DW; Chapman, D; Clary, C; Greist, JH; Harrison, W; Hoehn-Saric, R; Lydiard, B; McElroy, S; Ninan, P; Stahl, S; Zajecka, J1
Borgeat, F; Freeston, MH; Todorov, C1
Khanna, S; Kumar, TC1
Khanna, S; Kumar, TC; Raju, GV1
Hirschfeld, RM1
Kashnikova, AA; Kim, LV; Koren', EV; Tatarova, IN; Voloshina, VM1
Goldstein, A; Munera, PA1
Biederman, J; Cook, EH; Landau, P; March, JS; Messig, M; Wagner, KD; Wolkow, R1
Rabe-Jabłońska, J1
Greenberg, BD; Hoehn-Saric, R; McLeod, DR; Pearlson, GD; Schlaepfer, TE; Wong, SH1
Kane, JM1
Hackett, E; Koran, LM; Robinson, D; Rubin, A; Wolkow, R1
Carmin, CN; Gillock, KL; Wiegartz, PS; Yunus, U1
Austin, C; Bergeron, R; Chaput, Y; Goldner, E; Hadrava, V; Ravindran, AV; Swinson, R; van Ameringen, MA1
Albert, U; Bogetto, F; Maina, G1
McTavish, D; Murdoch, D1
Kriete, M; Rapoport, JL; Ryland, DH1
Chouinard, G1
Bullock, T; Fineberg, N; Montgomery, D; Montgomery, SA1
Berman, H; Salzman, C; Sapers, BL1
Bullock, T; Fineberg, NA; Montgomery, DB; Montgomery, SA1
Guthrie, SK1
Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P1
Baer, L; Holland, A; Jenike, MA; Minichiello, WE; Seymour, R; Summergrad, P1
Bick, PA; Chouinard, G; Gaffney, M; Goodman, W; Greist, J; Hackett, E; Jenike, M; Rasmussen, S; White, K1
Heym, J; Koe, BK1

Reviews

30 review(s) available for sertraline and Anankastic Personality

ArticleYear
Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis.
    Journal of psychiatric research, 2022, Volume: 148

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Humans; Network Meta-Analysis; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome

2022
Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case report and review of the literature.
    Neurocase, 2017, Volume: 23, Issue:2

    Topics: Adult; Humans; Longitudinal Studies; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Transcranial Direct Current Stimulation

2017
Moderators and predictors of response to cognitive behaviour therapy for pediatric obsessive-compulsive disorder: A systematic review.
    Psychiatry research, 2018, Volume: 261

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Predictive Value of Tests; Randomized Controlled Trials as Topic; Sertraline; Tic Disorders; Treatment Outcome

2018
Obsessive-Compulsive Disorder Following Cerebrovascular Accident: A Case Report and Literature Review.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:4

    Topics: Cerebral Angiography; Cerebrovascular Circulation; Endovascular Procedures; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Mental Status and Dementia Tests; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stents; Thrombolytic Therapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2019
The disaster was my fault!
    Neurocase, 2007, Volume: 13, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Compulsive Behavior; Ego; Humans; Internal-External Control; Longitudinal Studies; Male; Neuropsychological Tests; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Self Concept; September 11 Terrorist Attacks; Sertraline; Tourette Syndrome; Treatment Outcome

2007
[Trichotillomania and comorbidity--lamotrigine in a new perspective].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2008, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antidepressive Agents; Antimanic Agents; Anxiety; Behavior, Addictive; Bipolar Disorder; Child; Child Abuse; Comorbidity; Compulsive Behavior; Cyclothymic Disorder; Drug Therapy, Combination; Female; Humans; Impulsive Behavior; Lamotrigine; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Spouse Abuse; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazines; Trichotillomania

2008
Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5

    Topics: Adolescent; Antidepressive Agents; Child; Clomipramine; Humans; Obsessive-Compulsive Disorder; Research Design; Sertraline; Time Factors; Treatment Outcome

2011
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania

2003
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
    The Psychiatric clinics of North America, 2006, Volume: 29, Issue:2

    Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sertraline

2006
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted

2006
Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:12

    Topics: Antidepressive Agents; Child; Child Health Services; Cost-Benefit Analysis; Depressive Disorder, Major; Drugs, Generic; Humans; Obsessive-Compulsive Disorder; Quality Assurance, Health Care; Sertraline

2006
Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence.
    The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:3

    Topics: Adolescent; Anti-Anxiety Agents; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Fluvoxamine; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome

2007
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2007
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:4

    Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Placebos; Sertraline; Treatment Outcome

1995
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
    Archives of general psychiatry, 1995, Volume: 52, Issue:1

    Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1995
Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    International clinical psychopharmacology, 1994, Volume: 9 Suppl 3

    Topics: 1-Naphthylamine; Humans; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Treatment of obsessive compulsive disorder in the elderly: a review and case example.
    Journal of behavior therapy and experimental psychiatry, 1994, Volume: 25, Issue:2

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Behavior Therapy; Combined Modality Therapy; Desensitization, Psychologic; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
The pharmacotherapy of obsessive-compulsive disorder.
    Pharmacopsychiatry, 1993, Volume: 26 Suppl 1

    Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1993
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:2

    Topics: 1-Naphthylamine; Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
    Drug safety, 1996, Volume: 15, Issue:2

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan

1996
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 12

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:3

    Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Drugs, 1992, Volume: 44, Issue:4

    Topics: 1-Naphthylamine; Animals; Binding Sites; Brain; Depression; Drug Tolerance; Electroencephalography; Humans; Obsessive-Compulsive Disorder; Psychomotor Performance; Rats; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline

1992
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    International clinical psychopharmacology, 1992, Volume: 7 Suppl 2

    Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1992
Sertraline: a new serotonergic antidepressant.
    Hospital & community psychiatry, 1992, Volume: 43, Issue:7

    Topics: 1-Naphthylamine; Animals; Depressive Disorder; Humans; Obsessive-Compulsive Disorder; Sertraline

1992
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    International clinical psychopharmacology, 1992, Volume: 7 Suppl 1

    Topics: 1-Naphthylamine; Behavior Therapy; Clomipramine; Combined Modality Therapy; Depressive Disorder; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertraline

1992
Pharmacotherapy of obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline

1992
Sertraline: a new specific serotonin reuptake blocker.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:9

    Topics: 1-Naphthylamine; Aged; Alcohol Drinking; Animals; Appetite; Clinical Trials as Topic; Depression; Down-Regulation; Drug Interactions; Humans; Middle Aged; Obsessive-Compulsive Disorder; Psychomotor Performance; Serotonin Antagonists; Sertraline

1991
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    The American journal of psychiatry, 1990, Volume: 147, Issue:9

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline

1990
Pharmacology of sertraline: a review.
    The Journal of clinical psychiatry, 1988, Volume: 49 Suppl

    Topics: 1-Naphthylamine; Animals; Behavior, Animal; Body Weight; Depressive Disorder; Humans; Naphthalenes; Obsessive-Compulsive Disorder; Rats; Serotonin Antagonists; Sertraline

1988

Trials

54 trial(s) available for sertraline and Anankastic Personality

ArticleYear
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
    BMC psychiatry, 2022, 01-12, Volume: 22, Issue:1

    Topics: Double-Blind Method; Drug Therapy, Combination; Executive Function; Humans; Iran; Memantine; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2022
Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial.
    International clinical psychopharmacology, 2023, 01-01, Volume: 38, Issue:1

    Topics: Humans; Mirtazapine; Obsessive-Compulsive Disorder; Sertraline

2023
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
    BMC pharmacology & toxicology, 2022, 09-27, Volume: 23, Issue:1

    Topics: Double-Blind Method; Drug Therapy, Combination; Granisetron; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome

2022
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.
    BMC psychiatry, 2023, 09-21, Volume: 23, Issue:1

    Topics: Acetamides; Drug-Related Side Effects and Adverse Reactions; Humans; Iran; Obsessive-Compulsive Disorder; Sertraline

2023
Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial.
    Asian journal of psychiatry, 2018, Volume: 38

    Topics: Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult

2018
Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.
    Translational psychiatry, 2018, 04-18, Volume: 8, Issue:1

    Topics: Adult; Brain; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome; Young Adult

2018
Treatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTS.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2020, Volume: 59, Issue:2

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome

2020
Sertraline Effects on Striatal Resting-State Functional Connectivity in Youth With Obsessive-Compulsive Disorder: A Pilot Study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2019, Volume: 58, Issue:5

    Topics: Adolescent; Brain Mapping; Case-Control Studies; Child; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Obsessive-Compulsive Disorder; Pilot Projects; Sertraline

2019
Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
    Child psychiatry and human development, 2014, Volume: 45, Issue:2

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Compulsive Behavior; Depression; Female; Humans; Male; Obsessive Behavior; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Symptom Assessment

2014
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
    Behaviour research and therapy, 2013, Volume: 51, Issue:12

    Topics: Adolescent; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Obsessive-Compulsive Disorder; Patient Compliance; Sertraline; Treatment Outcome

2013
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
    European child & adolescent psychiatry, 2015, Volume: 24, Issue:5

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Denmark; Female; Humans; Male; Norway; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sweden; Treatment Outcome

2015
Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:5

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Tic Disorders; Treatment Outcome

2015
Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:7

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure

2015
Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.
    Journal of psychiatric research, 2015, Volume: 71

    Topics: Adolescent; Akathisia, Drug-Induced; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Emotions; Female; Humans; Inhibition, Psychological; Male; Models, Statistical; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2015
Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:6

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult

2016
The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder.
    Depression and anxiety, 2010, Volume: 27, Issue:4

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Executive Function; Female; Humans; Male; Mental Recall; Neuropsychological Tests; Obsessive-Compulsive Disorder; Psychomotor Performance; Sertraline; Wechsler Scales

2010
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression.
    Psychotherapy and psychosomatics, 2010, Volume: 79, Issue:5

    Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Journal of the American Academy of Child and Adolescent Psychiatry, 2010, Volume: 49, Issue:10

    Topics: Adolescent; Awareness; Child; Codependency, Psychological; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disability Evaluation; Female; Humans; Internal-External Control; Linear Models; Male; Obsessive-Compulsive Disorder; Parent-Child Relations; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline

2010
Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
    Psychotherapy and psychosomatics, 2011, Volume: 80, Issue:4

    Topics: Cognitive Behavioral Therapy; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Psychotherapy, Group; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors

2011
Maternal and child expressed emotion as predictors of treatment response in pediatric obsessive-compulsive disorder.
    Child psychiatry and human development, 2012, Volume: 43, Issue:3

    Topics: Adolescent; Analysis of Variance; Child; Child Behavior Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Expressed Emotion; Family; Female; Humans; Male; Mother-Child Relations; Mothers; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Self Report; Sertraline

2012
Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.
    Psychiatry research, 2013, Feb-28, Volume: 205, Issue:3

    Topics: Adolescent; Anxiety; Checklist; Child; Child Behavior; Depression; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation

2013
Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
    Journal of child and adolescent psychopharmacology, 2003, Volume: 13 Suppl 1

    Topics: Adolescent; Aging; Child; Female; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2003
Effects of sertraline on kinematic aspects of hand movements in patients with obsessive-compulsive disorder.
    Psychopharmacology, 2004, Volume: 171, Issue:2

    Topics: Adult; Biomechanical Phenomena; Female; Hand; Handwriting; Humans; Male; Motor Skills Disorders; Movement; Movement Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain

2004
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    JAMA, 2004, Oct-27, Volume: 292, Issue:16

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Can a subgroup of OCD patients with motor abnormalities and poor therapeutic response be identified?
    Psychopharmacology, 2005, Volume: 179, Issue:4

    Topics: Adult; Behavior Therapy; Biomechanical Phenomena; Combined Modality Therapy; Drug Resistance; Female; Handwriting; Humans; Male; Motor Skills; Movement Disorders; Nervous System Diseases; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Processing, Computer-Assisted

2005
Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:11

    Topics: Adolescent; Child; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline

2005
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome

2006
A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:7

    Topics: Adult; Ambulatory Care; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotherapy, Group; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome

2006
Do soft signs predict treatment outcome in obsessive-compulsive disorder?
    The Journal of neuropsychiatry and clinical neurosciences, 1995,Spring, Volume: 7, Issue:2

    Topics: 1-Naphthylamine; Adult; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1995
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    International clinical psychopharmacology, 1995, Volume: 10, Issue:2

    Topics: 1-Naphthylamine; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Archives of general psychiatry, 1995, Volume: 52, Issue:4

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:4

    Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Placebos; Sertraline; Treatment Outcome

1995
Combined SSRI-moclobemide treatment of psychiatric illness.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:1

    Topics: 1-Naphthylamine; Adult; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:12

    Topics: 1-Naphthylamine; Adolescent; Analysis of Variance; Blood Platelets; Carrier Proteins; Child; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tourette Syndrome

1996
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    The American journal of psychiatry, 1997, Volume: 154, Issue:9

    Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
The Brown Assessment of Beliefs Scale: reliability and validity.
    The American journal of psychiatry, 1998, Volume: 155, Issue:1

    Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Awareness; Brief Psychiatric Rating Scale; Delusions; Factor Analysis, Statistical; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Severity of Illness Index; Somatoform Disorders; Tape Recording; Treatment Outcome

1998
A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    International clinical psychopharmacology, 1997, Volume: 12, Issue:6

    Topics: 1-Naphthylamine; Adult; Aged; Dizziness; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders

1997
Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:4

    Topics: 1-Naphthylamine; Adolescent; Age Factors; Analysis of Variance; Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    JAMA, 1998, Nov-25, Volume: 280, Issue:20

    Topics: Adolescent; Antidepressive Agents; Child; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1998
Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:2

    Topics: Adult; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Sertraline

1999
Absence of cardiovascular adverse effects of sertraline in children and adolescents.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:5

    Topics: Adolescent; Antidepressive Agents; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Obsessive-Compulsive Disorder; Sertraline

1999
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Archives of general psychiatry, 2000, Volume: 57, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:3

    Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:10

    Topics: Adolescent; Child; Consumer Product Safety; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors

2001
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders.
    Psychiatry research, 2001, Nov-30, Volume: 108, Issue:2

    Topics: Adult; Aged; Blood Flow Velocity; Cerebral Cortex; Depressive Disorder, Major; Desipramine; Dominance, Cerebral; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Regional Blood Flow; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2001
Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
    The American journal of psychiatry, 2002, Volume: 159, Issue:1

    Topics: Adolescent; Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Patient Dropouts; Quality of Life; Recurrence; Sertraline; Single-Blind Method; Treatment Outcome

2002
Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:3

    Topics: Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Sertraline; Single-Blind Method

2002
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
    Archives of general psychiatry, 1992, Volume: 49, Issue:7

    Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer

1992
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    International clinical psychopharmacology, 1992, Volume: 7 Suppl 2

    Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1992
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    The American journal of psychiatry, 1990, Volume: 147, Issue:9

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline

1990
Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
    The American journal of psychiatry, 1990, Volume: 147, Issue:7

    Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Naphthalenes; Obsessive-Compulsive Disorder; Placebos; Serotonin; Serotonin Antagonists; Sertraline

1990
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:3

    Topics: 1-Naphthylamine; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Serotonin Antagonists; Sertraline

1990

Other Studies

92 other study(ies) available for sertraline and Anankastic Personality

ArticleYear
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder.
    Psychopharmacology bulletin, 2021, 11-03, Volume: 51, Issue:4

    Topics: Dose-Response Relationship, Drug; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence

2021
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
    Comprehensive psychiatry, 2022, Volume: 115

    Topics: Adolescent; Child; Drug Monitoring; Humans; Obsessive-Compulsive Disorder; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

2022
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine.
    European journal of hospital pharmacy : science and practice, 2023, Volume: 30, Issue:5

    Topics: Adolescent; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Rhabdomyolysis; Sertraline

2023
Re: "Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)" by Kolitsopoulos et al.
    Journal of child and adolescent psychopharmacology, 2023, Volume: 33, Issue:7

    Topics: Child; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2023
Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine.
    Journal of psychiatric practice, 2023, Nov-01, Volume: 29, Issue:6

    Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Precision Medicine; Selective Serotonin Reuptake Inhibitors; Sertraline

2023
Relapse of obsessive-compulsive disorder after cerebral venous sinus thrombosis: a case report.
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2020, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Recurrence; Sertraline; Sinus Thrombosis, Intracranial

2020
Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive-compulsive disorder: A real-world evidence analysis from the United States.
    International journal of clinical practice, 2021, Volume: 75, Issue:10

    Topics: Depressive Disorder, Major; Humans; Medication Adherence; Obsessive-Compulsive Disorder; Patient Acceptance of Health Care; Retrospective Studies; Sertraline; United States

2021
Sertraline induced cervical dystonia in a patient of Obsessive Compulsive Disorder.
    Asian journal of psychiatry, 2018, Volume: 31

    Topics: Adult; Humans; India; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Torticollis

2018
Social media and smartphone technology in the symptomatology of OCD.
    BMJ case reports, 2018, Aug-28, Volume: 2018

    Topics: Adult; Citalopram; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Smartphone; Social Media

2018
Editorial: Pharmacological Effects on Striatal Resting-State Connectivity in Pediatric Obsessive-Compulsive Disorder: An Opportunity to Modulate Neurodevelopmental Trajectories?
    Journal of the American Academy of Child and Adolescent Psychiatry, 2019, Volume: 58, Issue:5

    Topics: Adolescent; Child; Corpus Striatum; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Pilot Projects; Sertraline

2019
Periodic fever and hyperimmunoglobulin D syndrome in a boy with pediatric autoimmune neuropsychiatric disorders associated with group A β-Hemolytic streptococcus.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:4

    Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Child; Humans; Male; Mevalonate Kinase Deficiency; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Streptococcal Infections; Streptococcus pyogenes; Stuttering; Tourette Syndrome

2013
Clozapine-induced obsessive-compulsive symptoms in bipolar disorder.
    The American journal of psychiatry, 2013, Volume: 170, Issue:8

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Recurrence; Sertraline

2013
P300 in obsessive-compulsive disorder: source localization and the effects of treatment.
    Journal of psychiatric research, 2013, Volume: 47, Issue:12

    Topics: Adolescent; Adult; Antidepressive Agents; Brain Mapping; Case-Control Studies; Cognitive Behavioral Therapy; Electroencephalography; Event-Related Potentials, P300; Female; Frontal Lobe; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Sertraline; Young Adult

2013
Extraordinarily fast response to low-dose sertraline in a child with severe obsessive-compulsive disorder and high functioning serotonin transporter genotype.
    Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:2

    Topics: Child; Genotype; Humans; Male; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors

2014
Do antidepressant-induced manic episodes in obsessive-compulsive disorder patients represent the clinical expression of an underlying bipolarity?
    The Australian and New Zealand journal of psychiatry, 2014, Volume: 48, Issue:10

    Topics: Antidepressive Agents; Bipolar Disorder; Comorbidity; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Sertraline

2014
1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
    European archives of psychiatry and clinical neuroscience, 2015, Volume: 265, Issue:3

    Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Choline; Creatine; Female; Follow-Up Studies; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Protons; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult

2015
[Olfactory reference syndrome and hyperhidrosis: comorbidity in one patient].
    Revista de neurologia, 2014, Dec-16, Volume: 59, Issue:12

    Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Substitution; Halitosis; Hallucinations; Humans; Hyperhidrosis; Male; Models, Psychological; Obsessive-Compulsive Disorder; Psychotropic Drugs; Sertraline; Syndrome

2014
Treatment of internet addiction in patient with panic disorder and obsessive compulsive disorder: a case report.
    CNS & neurological disorders drug targets, 2015, Volume: 14, Issue:3

    Topics: Behavior, Addictive; Clonazepam; Cognitive Behavioral Therapy; Female; Humans; Internet; Obsessive-Compulsive Disorder; Panic Disorder; Psychiatric Status Rating Scales; Psychotropic Drugs; Sertraline; Treatment Outcome; Young Adult

2015
Serotonin syndrome precipitated by sertraline and discontinuation of clozapine.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:8

    Topics: Clozapine; Drug Administration Schedule; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Treatment Outcome

2015
Topiramate augmentation in a patient with obsessive-compulsive disorder.
    Journal of psychiatry & neuroscience : JPN, 2015, Volume: 40, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal

2015
The girl who would not sit--case report.
    Psychiatria Danubina, 2015, Volume: 27 Suppl 1

    Topics: Culture; Depressive Disorder; Ethnicity; Fear; Female; Housing; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Sertraline; Social Isolation; Social Stigma; Social Values; United Kingdom; Young Adult

2015
[The Usefulness of Clonazepam as an Augmentative Treatment in a Case of Severe Childhood Onset Obsessive-Compulsive Disorder].
    Turk psikiyatri dergisi = Turkish journal of psychiatry, 2015,Winter, Volume: 26, Issue:4

    Topics: Adolescent; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; GABA Modulators; Humans; Obsessive-Compulsive Disorder; Olanzapine; Sertraline; Severity of Illness Index; Turkey

2015
Recent NIMH clinical trials and implications for practice.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:12

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride

2008
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
    Depression and anxiety, 2009, Volume: 26, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

2009
Hyperpigmentation with amisulpride.
    The Australian and New Zealand journal of psychiatry, 2009, Volume: 43, Issue:1

    Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride

2009
An uncontrollable gambling addiction.
    Bratislavske lekarske listy, 2008, Volume: 109, Issue:10

    Topics: Antidepressive Agents; Behavior, Addictive; Gambling; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychotherapy; Sertraline

2008
Onychophagia as a spectrum of obsessive-compulsive disorder.
    Acta dermato-venereologica, 2009, Volume: 89, Issue:3

    Topics: Adolescent; Adult; Clomipramine; Female; Humans; Nail Biting; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2009
Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers.
    Biological psychiatry, 2009, Dec-15, Volume: 66, Issue:12

    Topics: Adult; Cocaine; Diencephalon; Drug Administration Routes; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Protein Binding; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Young Adult

2009
Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
    Journal of child and adolescent psychopharmacology, 2010, Volume: 20, Issue:2

    Topics: Child; Enuresis; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2010
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential study.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:3

    Topics: Acoustic Stimulation; Adult; Auditory Cortex; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Treatment Outcome; Young Adult

2010
[Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:8

    Topics: Antidepressive Agents; Child; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2010
Treatment practices in Tourette syndrome: the European perspective.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome

2012
[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:11 Pt 2

    Topics: Adolescent; Antidepressive Agents; Child; Comorbidity; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2012
[Severe trichotillomania associated with obsessive ideation].
    The Pan African medical journal, 2012, Volume: 13

    Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Sertraline; Severity of Illness Index; Treatment Outcome; Trichotillomania; Valproic Acid

2012
Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline.
    Neuropsychiatry, neuropsychology, and behavioral neurology, 2002, Volume: 15, Issue:3

    Topics: Adult; Female; Humans; Huntington Disease; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure.
    Pediatrics in review, 2002, Volume: 23, Issue:12

    Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents; Antitussive Agents; Anxiety Disorders; Child; Dextromethorphan; Diagnosis, Differential; Drug Interactions; Female; Fluvoxamine; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Syndrome; Sertraline

2002
Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:11

    Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Personality Assessment; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Sertraline

2002
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:5

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Drug Therapy, Combination; Humans; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2003
Early-onset obsessive-compulsive disorder.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:5

    Topics: Adolescent; Age Factors; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2003
Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD.
    Psychiatry research, 2003, Oct-30, Volume: 124, Issue:2

    Topics: Adult; Arousal; Caudate Nucleus; Cerebral Cortex; Cues; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2003
Kinematical analysis of emotionally induced facial expressions in patients with obsessive-compulsive disorder.
    Psychological medicine, 2003, Volume: 33, Issue:8

    Topics: Adult; Biomechanical Phenomena; Dose-Response Relationship, Drug; Drug Administration Schedule; Emotions; Facial Expression; Facial Muscles; Female; Humans; Laughter; Male; Middle Aged; Motion Pictures; Obsessive-Compulsive Disorder; Reaction Time; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Wit and Humor as Topic

2003
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
    Prescrire international, 2004, Volume: 13, Issue:73

    Topics: Adolescent; Adult; Child; Drug Approval; Fluoxetine; France; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2004
Symptomatic depression after long-term steroid treatment: a case report.
    African journal of medicine and medical sciences, 2004, Volume: 33, Issue:3

    Topics: Adult; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Glucocorticoids; Hepatitis C, Chronic; Humans; Male; Obsessive-Compulsive Disorder; Prednisone; Sertraline

2004
Serotonin syndrome: a case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88, Issue:7

    Topics: Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline

2005
Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epilepsy; Female; Genotype; Humans; Isoenzymes; Obsessive-Compulsive Disorder; Pharmacogenetics; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline

2006
Bulimic forms of anorexia nervosa--case report no.1.
    The Journal of the Egyptian Public Health Association, 2003, Volume: 78, Issue:1-2

    Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Bulimia Nervosa; Female; Humans; Obsessive-Compulsive Disorder; Sertraline

2003
Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    Biological psychiatry, 2007, Feb-01, Volume: 61, Issue:3

    Topics: Acute Disease; Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Tic Disorders; Tourette Syndrome

2007
Punding as a complication of brain stem stroke?: report of a case.
    Stroke, 2007, Volume: 38, Issue:4

    Topics: Basilar Artery; Brain; Brain Stem; Brain Stem Infarctions; Cerebral Angiography; Dopamine; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Stereotypic Movement Disorder; Treatment Outcome; Vertebrobasilar Insufficiency

2007
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
    Depression and anxiety, 2008, Volume: 25, Issue:2

    Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline

2008
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Fluoxetine; Humans; Male; Mental Status Schedule; Obsessive-Compulsive Disorder; Referral and Consultation; Sertraline; Tourette Syndrome; Trichotillomania

2007
Priapism associated with sertraline.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:7

    Topics: Adolescent; Humans; Male; Obsessive-Compulsive Disorder; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline

2007
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10

    Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2007
Sertraline and tic: case report.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:6

    Topics: Adult; Depressive Disorder, Major; Eyelids; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereotyped Behavior; Tics

2007
Obsessive-compulsive disorder secondary to a right parietal lobe haemorrhage: a case report.
    Acta neurologica Belgica, 2007, Volume: 107, Issue:3

    Topics: Adult; Cerebral Hemorrhage; Cerebrum; Headache; Humans; Magnetic Resonance Imaging; Male; Nausea; Obsessive-Compulsive Disorder; Parietal Lobe; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2007
Addition of trazodone to sertraline: a probable synergistic action in a case of obsessive-compulsive disorder.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2007, Volume: 29, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Trazodone

2007
Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:7

    Topics: Antipsychotic Agents; Child, Preschool; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline

2008
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder].
    Turk psikiyatri dergisi = Turkish journal of psychiatry, 2008,Spring, Volume: 19, Issue:1

    Topics: Adult; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2008
One year follow-up of postpartum-onset obsessive-compulsive disorder: a case series.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, May-15, Volume: 32, Issue:4

    Topics: Adult; Female; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Postpartum Period; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline

2008
Buspirone augmentation of sertraline.
    The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:6

    Topics: 1-Naphthylamine; Adult; Anorexia Nervosa; Antidepressive Agents; Buspirone; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Sertraline

1995
Valproate pretreatment for the difficult-to-treat patient with OCD.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:11

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid

1994
Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    The American journal of psychiatry, 1994, Volume: 151, Issue:7

    Topics: 1-Naphthylamine; Clozapine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Pharmacologic management of obsessive-compulsive disorder.
    Southern medical journal, 1994, Volume: 87, Issue:3

    Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone

1994
Panic attacks precipitated by sertraline.
    The American journal of psychiatry, 1994, Volume: 151, Issue:1

    Topics: 1-Naphthylamine; Adult; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Serotonin reuptake blockers for the treatment of obsessional jealousy.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:1

    Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Sertraline and mental retardation with obsessive-compulsive disorder.
    The American journal of psychiatry, 1993, Volume: 150, Issue:8

    Topics: 1-Naphthylamine; Adult; Female; Humans; Intellectual Disability; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

1993
Sertraline in the treatment of neurotic excoriations and related disorders.
    Archives of dermatology, 1996, Volume: 132, Issue:5

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin Diseases

1996
Medication optimization during clozapine treatment.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7

    Topics: 1-Naphthylamine; Adult; Clozapine; Drug Therapy, Combination; Humans; Lithium; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Valproic Acid

1996
High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    The American journal of psychiatry, 1996, Volume: 153, Issue:9

    Topics: 1-Naphthylamine; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3

    Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Inability to cry during SRI treatment.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:12

    Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors

1996
Sertraline and akathisia: spontaneous resolution.
    Biological psychiatry, 1997, Jan-15, Volume: 41, Issue:2

    Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Neurologic Examination; Obsessive-Compulsive Disorder; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    The American journal of psychiatry, 1997, Volume: 154, Issue:4

    Topics: 1-Naphthylamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Pica and the obsessive-compulsive spectrum disorders.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996, Volume: 86, Issue:12 Suppl

    Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Citalopram; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pica; Sertraline; Tomography, Emission-Computed, Single-Photon

1996
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
    Journal of child and adolescent psychopharmacology, 1996,Summer, Volume: 6, Issue:2

    Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine

1996
Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
    Journal of child and adolescent psychopharmacology, 1996,Fall, Volume: 6, Issue:3

    Topics: 1-Naphthylamine; Adolescent; Behavior Therapy; Child; Combined Modality Therapy; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
    The American journal of psychiatry, 1998, Volume: 155, Issue:11

    Topics: Adult; Clozapine; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Urinary retention with sertraline, haloperidol, and clonazepam combination.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:10

    Topics: Adult; Antipsychotic Agents; Clonazepam; Comorbidity; Constipation; Delusions; Drug Therapy, Combination; Female; GABA Modulators; Haloperidol; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Retention

1998
Sertraline in the treatment of obsessive-compulsive disorder.
    American family physician, 1999, Jan-01, Volume: 59, Issue:1

    Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration

1999
Serotonin syndrome in a child associated with erythromycin and sertraline.
    Pharmacotherapy, 1999, Volume: 19, Issue:7

    Topics: Anti-Bacterial Agents; Child; Erythromycin; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline

1999
A possible tetracycline-risperidone-sertraline interaction in an adolescent.
    The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 1999,Spring, Volume: 6, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Protein Synthesis Inhibitors; Risperidone; Sertraline; Tetracyclines; Tourette Syndrome

1999
Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    The American journal of psychiatry, 1999, Volume: 156, Issue:11

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
    The Australian and New Zealand journal of psychiatry, 2000, Volume: 34, Issue:3

    Topics: Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Humans; Lamotrigine; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazines

2000
Seizures associated with sertraline.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:5

    Topics: Adult; Female; Humans; Male; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline

2000
Sertraline in the treatment of anxiety disorders.
    Depression and anxiety, 2000, Volume: 11, Issue:4

    Topics: Adult; Clinical Trials as Topic; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Quality of Life; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome

2000
Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire international, 2000, Volume: 9, Issue:48

    Topics: Adult; Clinical Trials as Topic; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2000
[Sertraline in child and adolescent psychiatry].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2001, Volume: 101, Issue:8

    Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires

2001
Migraine and sertraline.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:10

    Topics: Child; Humans; Male; Migraine Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
[The difference between obsessive-compulsive disorder in adolescence and in adults].
    Przeglad lekarski, 2001, Volume: 58 Suppl 3

    Topics: Adolescent; Adult; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Extending indications for long-term pharmacotherapy: opportunities and challenges.
    The American journal of psychiatry, 2002, Volume: 159, Issue:1

    Topics: Bulimia; Chronic Disease; Fluoxetine; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Sertraline

2002
Treatment of late-onset OCD following basal ganglia infarct.
    Depression and anxiety, 2002, Volume: 15, Issue:2

    Topics: Aged; Basal Ganglia Cerebrovascular Disease; Cerebral Infarction; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Drug Therapy, Combination; Humans; Lorazepam; Male; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome

2002
Sertraline: new indication. May help children with obsessive-compulsive disorder.
    Prescrire international, 2002, Volume: 11, Issue:59

    Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
Selective serotonin reuptake inhibitors in OCD.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: 1-Naphthylamine; Clomipramine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertraline

1992